ADMA Biologics Inc (ADMA) Company Report Dec. 07, 2022, 00:04 UTC 86 0 comments ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate Comment Full text
Lexaria Bioscience Corp. (LEXX) Company Report Dec. 06, 2022, 22:40 UTC 86 0 comments New SEC Form for Lexaria Bioscience Corp. Comment Full text
Journey Medical Corporation (DERM) Company Report Dec. 06, 2022, 00:10 UTC 90 0 comments Journey Medical Corporation to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference Comment Full text
Veru Inc. (VERU) Company Report Dec. 05, 2022, 23:30 UTC 84 0 comments New SEC Form for Veru Inc. Comment Full text
Cytokinetics Inc (CYTK) Company Report Dec. 03, 2022, 00:05 UTC 86 0 comments Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Comment Full text
Rigel Pharmaceuticals Inc (RIGL) Company Report Dec. 02, 2022, 01:05 UTC 85 0 comments Rigel Announces U.S. FDA Approval of REZLIDHIA™(olutasidenib) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation Comment Full text
Cytokinetics Inc (CYTK) Company Report Dec. 02, 2022, 00:05 UTC 83 0 comments Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND Comment Full text
Luna Innovations Incorporated (LUNA) Company Report Dec. 01, 2022, 16:50 UTC 83 0 comments Luna to Present at Singular Research’s Best of the Uncovered Investor Conference on December 8, 2022 Comment Full text
Abcam Plc (ABCM) Company Report Nov. 30, 2022, 12:05 UTC 87 0 comments Abcam Plc Notification Comment Full text
Arrowhead Pharmaceuticals Inc (ARWR) Company Report Nov. 29, 2022, 00:20 UTC 86 0 comments New Form 10-K for Arrowhead Pharmaceuticals, Inc. Comment Full text